Trials / Completed
CompletedNCT01016691
Safety and Efficacy of a Drug Delivery System in Glaucoma
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 47 (actual)
- Sponsor
- Vistakon Pharmaceuticals · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of the ocular safety and efficacy of a drug delivery system in open-angle glaucoma or ocular hypertension.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | High Dose Drug Device | device inserted for 4 days |
| DRUG | Low Dose Drug Device | device inserted for 4 days |
| DRUG | Placebo Device | device inserted for 4 days |
| DRUG | bimatoprost 0.03% | one drop in each eye on one day only |
Timeline
- Start date
- 2009-10-01
- Primary completion
- 2010-02-01
- First posted
- 2009-11-19
- Last updated
- 2015-03-06
- Results posted
- 2012-01-27
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01016691. Inclusion in this directory is not an endorsement.